Ilana Halperin Sunnybrook Health Sciences Centre, Toronto, ON, Canada Ilana Halperin is a full-time staff physician and Assistant Professor in the job description of Clinician in Quality and Innovation. Dr Halperin has a BSc from McGill University, Canada, and an MD from the University of Western Ontario, Canada; she completed internal medicine and endocrinology training at the University of Toronto, Canada, and received an MSc in Quality Improvement and Patient Safety at the Institute for Health Policy, Management and Evaluation, University of Toronto. She was an early adopter of digital tools and virtual care and was recently named as physician lead for the digital and virtual care taskforce at Sunnybrook Health Sciences Centre, Canada, where she practices. Dr Halperin has a large Type 1 diabetes practice with a special interest in young adults and pregnant women and has been asked to speak numerous times on how to integrate technology into virtual diabetes visits.

Dr. Rocio Harbison is board certified in Endocrinology. She graduated from the University of Puerto Rico. She completed her Internal Medicine Residency at St Vincent’s Hospital in Indianapolis, Indiana and her Fellowship in Endocrinology, Diabetes, and Metabolism at the University of Michigan in Ann Arbor, Michigan. She was faculty at the University of Texas Health Science Center Houston and worked in a large group practice prior to founding Advanced Endocrinology and Diabetes Clinic in Houston, TX. She has been voted one of Houston’s Top Doctors by HTexas Magazine, one of Texas Monthly’s 2015 Rising Stars and voted Top Doctor by Houstonia Magazine. Dr. Harbison believes that the patient physician relationship is a partnership focused on the long-term health and well-being. Dr. Harbison enjoys keeping an active and healthy lifestyle which she shares with her 5 kids and husband. Dr. Harbison is fluent in English and Spanish.

Sara Hartnell is Lead Diabetes Specialist Dietitian & Insulin pump educator working within the Nutrition and Dietetics Department and the Institute of Metabolic Sciences Wolfson Diabetes and Endocrinology Clinic (IMS-WDEC) at Cambridge University Hospitals NHS Foundation Trust. She manages a team of over 20 dietitians covering Adult Metabolics, Obesity, Diabetes, Endocrinology and Cardiology. Sara has a special interest in Type 1 diabetes, with a specific focus in intensified management including structured education and use of new technology; insulin pumps, CGMS and automated insulin delivery Sara and her team support various academic and commercial diabetes related research projects within department including Professor Hovorka’s Closed Loop research. Sara is a member of the Diabetes Technology Network committee and a director of a small limited company (ASK Diabetes Ltd) which provides diabetes education to Health Care Professionals and consultancy to CamDiab Ltd.

Ali Hashemi is the Co-Founder of Glucare and an investor in early-stage ventures at the intersection of health and technology, with a particular focus on applying deep learning and complex algorithms to solve challenging problems in healthcare. Ali was previously the founder of Amana Healthcare, the benchmark and fastest-growing continuum-of-care hospital platform in the Middle East, acquired by Mubadala Healthcare in 2018 in what was among the most significant deals in regional healthcare M&A. Ali previously founded and led the Middle East Healthcare Practice at Booz & Company, based out of Dubai. Before joining Booz&Co, Ali was a member of the Healthcare Practice and the Private Equity Practice at Bain & Company, based in New York City. Ali studied Medicine and received his MBA concurrently from McGill University. He received a B.S.E. with Distinction from Duke University with a dual major in BioMedical Engineering and Religion and a minor in Chemistry.

Lutz Heinemann studied Process Engineering at the University of Applied Sciences, Düsseldorf, Germany, receiving his degree in 1976, and went on to study Biology at the University of Düsseldorf, qualifying as a Biologist in 1982. After three years as Assistant Professor in the Neurophysiology Department at Düsseldorf University, working with Professor J. Haase, Professor Heinemann transitioned to the field of Internal Medicine. He went on to work with Professor M. Berger at the Clinic for Nutrition and Metabolism in the Centre for Internal Medicine and Neurology from 1985 to 1999. In 1999, Professor Heinemann founded his own company, the Profil Institute for Metabolic Research in Neuss, Germany, where he remained as CEO until 2009. Professor Heinemann is a member of the German Diabetes Association (DDG) and the European Association for the Study of Diabetes (EASD). He also sits on the Scientific Advisory Boards of various pharmaceutical and diagnostics companies. Since 2011, he has been the Managing Editor of the Journal of Diabetes Science and Technology. Professor Heinemann’s scientific research is focused on insulin pharmacology and diabetes technology. Between 2010 and 2015, he acted as coordinator for the EU-funded project AP@home. In 2007 he received an award for “Leadership in Diabetes Technology” from the Diabetes Technology Society and, in 2012, was granted the “Artificial Pancreas Research Award” by the Diabetes Technology Society.

Bruce is uMotif’s entrepreneurial leader and co-founded the company in 2012. He and his team have designed and built the uMotif patient-centric data capture platform powering site-based to fully decentralised clinical, real-world, and post-marketing research. Bruce began his career working in clinical trials at British Biotech before joining the UK Civil Service Fast Stream in the Department for Culture, Media and Sport. Prior to founding uMotif, Bruce was a Management Consultant at Serco and holds an Executive MBA from Imperial College Business School. Bruce was recognised in the 2019 PharmaVOICE 100 as one of the most innovative entrepreneurs in life sciences and has also been nominated as one of Computer Weekly’s UKtech50 Rising Stars, won the Cisco BIG awards, and was nominated by Real Business magazine as one of the ’30 to watch in mobile’.